Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of…
CertaraJanuary 7, 2026
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
CertaraDecember 18, 2025
Accelerated ADC Approval Through Expert Modeling and Data Rescue
See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…
CertaraDecember 15, 2025
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
CertaraDecember 12, 2025
New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
CertaraDecember 10, 2025
QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™
Japan: February 26, 2026 - 1:00 - 5:00 pm | Korea: Wednesday, March 4, 2026…
CertaraDecember 9, 2025
Virtual Triplets: The Next Step in Personalized and Ethical Drug Development
Learn how virtual triplets, linking PBPK, QSP, and organ-on-a-chip technologies, are transforming model-informed drug development,…
CertaraDecember 9, 2025
Expedited Pharmacometrics Regulatory Submissions
Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…
CertaraDecember 8, 2025
